Tilray Brands (TLRY) Change in Inventory (2017 - 2026)
Tilray Brands (TLRY) posted Change in Inventory of $9.1 million for Q1 2026, up 2115.33% on a QoQ basis from $411000.0 in Q4 2025, and up 457.06% year-over-year from $1.6 million in Q1 2025.
Tilray Brands (TLRY) Change in Inventory (2017 - 2026) Analysis & Trends
Tilray Brands' Change in Inventory history runs 10 years deep, the most recent figure standing at $9.1 million for Q1 2026.
- Quarterly Change in Inventory rose 457.06% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $29.4 million (up 77.93% YoY) and the FY2025 annual result came in at $13.6 million, down 12.95% from the prior year.
- Change in Inventory was $9.1 million for Q1 2026 at Tilray Brands, up from $411000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $29.2 million in Q2 2022 and bottomed at -$5.3 million in Q4 2022.
- A 5-year average of $6.6 million and a median of $8.0 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory plunged 1673.28% — and 2024, when it jumped 872.38%.
- Tilray Brands' Change in Inventory stood at -$5.3 million in 2022, then advanced by 4.91% to -$5.0 million in 2023, then gained by 15.2% to -$4.3 million in 2024, then soared by 109.66% to $411000.0 in 2025, then surged by 2115.33% to $9.1 million in 2026.
- Business Quant data shows TLRY's Change in Inventory at $9.1 million in Q1 2026, $411000.0 in Q4 2025, and $11.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 9.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 9.11 Mn |
| Feb 28, 2026 | 9.11 Mn |
| Nov 30, 2025 | 411,000.00 |
| Nov 30, 2025 | 411,000.00 |
| Aug 31, 2025 | 11.91 Mn |
| Aug 31, 2025 | 11.91 Mn |
| May 31, 2025 | 7.98 Mn |
| May 31, 2025 | 7.98 Mn |
| Feb 28, 2025 | -2.55 Mn |
| Feb 28, 2025 | -2.55 Mn |
| Nov 30, 2024 | -4.26 Mn |
| Nov 30, 2024 | -4.26 Mn |
| Aug 31, 2024 | 12.38 Mn |
| Aug 31, 2024 | 12.38 Mn |
| May 31, 2024 | 10.95 Mn |
| May 31, 2024 | 10.95 Mn |
| Feb 29, 2024 | 13.30 Mn |
| Feb 29, 2024 | 13.30 Mn |
| Nov 30, 2023 | -5.02 Mn |
| Nov 30, 2023 | -5.02 Mn |